SciClone Pharmaceuticals

SciClone Pharmaceuticals is a profit-generating specialty pharmaceutical company centered in China, with commercial operations and a range of products treating cancer, infectious diseases, and disorders of the cardiovascular, urological, respiratory, and central nervous systems. Headquartered in California, USA, the company conducts drug research and development in the United States, while its sales operations are primarily based in China. Its current flagship product, Zadaxin (Thymalfasin), is an immunomodulatory agent mainly used for hepatitis B treatment, with over 90% of its sales occurring in China.